bpc-157 human clinical trial tendon injury randomized Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats BPC-157: What the Science Actually
Description
What It Helps Support
Bachelet I, Munitz A, Levi-Schaffer F
Cmo se almacena para mantener su estabilidad
In a randomised clinical trial involving five treatment arms with doses of between 2.5 g/day and 1000 g/day, Eussen [33] concluded that a dose of at least 600 g/day was required to obtain adequate results
